Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents

  • Yizhou Dong
  • , Qian Shi
  • , Kyoko Nakagawa-Goto
  • , Pei Chi Wu
  • , Susan L. Morris-Natschke
  • , Arnold Brossi
  • , Kenneth F. Bastow
  • , Jing Yu Lang
  • , Mien Chie Hung
  • , Kuo Hsiung Lee

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

6-Phenyl-4H-furo[3,2-c]pyran-4-one derivatives based on neo-tashinlactone (1) were synthesized and evaluated as novel anti-breast cancer agents. Compounds 10-13, 23, 25, and 27 showed potent inhibition against the SK-BR-3 breast cancer cell line. Importantly, 25 and 27 showed the highest cancer cell line selectivity, being approximately 100-250-fold more potent against SK-BR-3 (ED50 0.28 and 0.44 μM, respectively) compared with other cancer cell lines tested. In addition, 25 displayed low cytotoxicity against normal breast cell lines 184A1 and MCF10A. Compounds 25 and 27 merit further investigation in our continuing program to generate and develop selective anti-breast cancer agents.

Original languageEnglish
Pages (from-to)803-808
Number of pages6
JournalBioorganic and Medicinal Chemistry
Volume18
Issue number2
DOIs
StatePublished - 15 Jan 2010
Externally publishedYes

Keywords

  • 6-Phenyl-4H-furo[3,2-c]pyran-4-ones
  • Breast cancer
  • Neo-tanshinlactone

Fingerprint

Dive into the research topics of 'Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents'. Together they form a unique fingerprint.

Cite this